The development of AI is producing multiple winners and losers among programming languages. The best-known languages in datasets regularly produce better, ...
DAEJEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of ...
JDK 27, due in September, kicks off with a post-quantum hybrid key exchange proposal to bolster the security of network communications. Java Development Kit (JDK) 27, a release of standard Java ...
BOTHELL, Wash., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs ...
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with ...
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities supporting global ...
WESTLAKE VILLAGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (TTRX) (“Turn” or the “Company”), a clinical-stage biotechnology company developing next-generation dermatology, wound, ...
Microsoft has announced that it will raise the price of Xbox development kits once again, citing “macroeconomic conditions” as the reason. This move could significantly affect the cost of development ...
BenchSci, a disease biology generative AI platform, announced a three-year agreement with biopharmaceutical company Sanofi to deploy and use its Ascend platform throughout Sanofi's preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results